Indeed, enzymatic degradation of asparagine by L-asparaginase (ASNase, converting asparagine into aspartic acid and ammonia) treatment exhibits efficient tumor regression in acute lymphoblastic leukemia (ALL) and is the most successful and best documented nutrient dependency-targeting therapy in anti-cancer treatments (27). This evidence concerns the gene ASPG and cancer.